Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 8:13:956344.
doi: 10.3389/fphys.2022.956344. eCollection 2022.

Research progress on the relationship between autophagy and chronic complications of diabetes

Xia Ge  1 , Ling Wang  2 , Aihua Fei  1 , Shandong Ye  3 , Qingping Zhang  4
Affiliations
Review

Research progress on the relationship between autophagy and chronic complications of diabetes

Xia Ge et al. Front Physiol. .

Abstract

Diabetes is a common metabolic disease whose hyperglycemic state can induce diverse complications and even threaten human health and life security. Currently, the treatment of diabetes is restricted to drugs that regulate blood glucose and have certain accompanying side effects. Autophagy, a research hotspot, has been proven to be involved in the occurrence and progression of the chronic complications of diabetes. Autophagy, as an essential organismal defense mechanism, refers to the wrapping of cytoplasmic proteins, broken organelles or pathogens by vesicles, which are then degraded by lysosomes to maintain the stability of the intracellular environment. Here, we review the relevant aspects of autophagy and the molecular mechanisms of autophagy in diabetic chronic complications, and further analyze the impact of improving autophagy on diabetic chronic complications, which will contribute to a new direction for further prevention and treatment of diabetic chronic complications.

Keywords: autophagy; chronic complications; diabetes drug; molecular mechanism; regulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
General process of autophagy. Autophagy is a process that engulfs its own cytoplasmic proteins or organelles and encapsulates them into vesicles and fuses with lysosomes to form autolysosomes that degrade their encapsulated contents, realizing the cell’s own metabolic needs and the renewal of certain organelles.
FIGURE 2
FIGURE 2
Diabetes complications. The high-glucose state of diabetes can contribute to diverse complications such as diabetic microangiopathy and peripheral neuropathy. Some of these diabetic microangiopathies involve retinopathy, nephropathy and heart disease, such as Retinopathy, Blind, Nephropathy, Proteinuria, Podocytes, Vascular and Cardiomyopathy. In contrast, peripheral neuropathy presents with Amputation and Schwann cells.
FIGURE 3
FIGURE 3
Molecular mechanisms of autophagy associated with chronic complications of diabetes. mTORC1 regulates the initiation of autophagy by inhibiting the phosphorylation of the ULK1 complex and has a bidirectional effect on pancreatic β-cells. AMPK can impact autophagy by activating phosphorylation of ULK1 or regulating the PI3K complex. Autophagy and ROS can be mediated by each other. ROS activates autophagy by increasing beclin-1 expression and over-suppressing mTORC1, while autophagy can maintain ROS levels by clearing mitochondria. ER is an essential site of protein folding, while ER stress-mediated autophagy is associated with IRE1α, PERK, ATF6 and Ca2+ signaling pathways.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Al-Bari M. A. A., Xu P. (2020). Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways. Ann. N. Y. Acad. Sci. 1467 (1), 3–20. 10.1111/nyas.14305 - DOI - PubMed
    1. Alexander A., Cai S. L., Kim J., Nanez A., Sahin M., MacLean K. H., et al. (2010). ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. U. S. A. 107 (9), 4153–4158. 10.1073/pnas.0913860107 - DOI - PMC - PubMed
    1. Arden C. (2018). A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagy. Peptides 100, 85–93. 10.1016/j.peptides.2017.12.002 - DOI - PubMed
    1. Barlow A. D., Thomas D. C. (2015). Autophagy in diabetes: β-Cell dysfunction, insulin resistance, and complications. DNA Cell Biol. 34 (4), 252–260. 10.1089/dna.2014.2755 - DOI - PubMed
    1. Barutta F., Bellini S., Kimura S., Hase K., Corbetta B., Corbelli A., et al. (2022). Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy. Autophagy, 1–20. 10.1080/15548627.2022.2080382 - DOI - PMC - PubMed

LinkOut - more resources